triphenylethylene has been researched along with tamoxifen in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (40.91) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Arnstein, HR; Cannon, M; Halliwell, B; Smith, C; Wiseman, H | 1 |
| Clark, JH; Guthrie, S | 1 |
| Barrera, G; Dianzani, MU; Farina, A; Ferretti, C; Frati, L; Gulino, A; Paradisi, L; Parola, M; Screpanti, I; Vacca, A | 1 |
| Barrera, G; Dianzani, MU; Farina, A; Ferretti, C; Frati, L; Gulino, A; Screpanti, I; Vacca, A | 1 |
| Anderson, BW; O'Brian, CA; Ward, NE | 1 |
| Liskamp, RM; O'Brian, CA; Solomon, DH; Weinstein, IB | 1 |
| Clark, JH; Guthrie, SC; Mitchell, WC | 1 |
| Farina, A; Frati, L; Gulino, A; Modesti, A; Screpanti, I; Vacca, A | 1 |
| Papendorp, JT; Sonnenschein, C; Soto, AM | 1 |
| Clark, JH; Guthrie, SC; Winneker, RC | 1 |
| Blankenstein, MA; Thijssen, JH; van den Koedijk, CD | 1 |
| Blankenstein, MA; Govers, RM; Thijssen, JH; van den Koedijk, CD | 1 |
| Chiappetta, C; Hyder, SM; Stancel, GM | 1 |
| Bérubé, G; Gaudreault, RC; Séné, A | 1 |
| De Los Reyes, A; England, G; Jordan, VC; Lee, ES; O'Regan, RM; Schafer, JM; Yao, K | 1 |
| Clegg, NJ; Scanlan, TS; Weatherman, RV | 1 |
| Bahamonde, MI; Diaz, M; Hardy, SP; Lock, H; Muñoz, FJ; Posas, F; Valverde, MA | 1 |
| Blackmore, PF; Chatterjie, N; Dobrydneva, Y; Fichandler, CE; Fitzgerald, MC; Morrell, MM; Trebley, JP; Weatherman, RV | 1 |
| Barth, BM; Cabot, MC; Claxton, DF; Feith, DJ; Fox, TE; Kester, M; Loughran, TP; Morad, SA; Tan, SF | 1 |
| Abderrahman, B; Curpan, RF; Fan, P; Fanning, SW; Greene, GL; Greenland, JA; Jordan, VC; Maximov, PY; Rajan, SS; Rincon, DMQ; Sengupta, S | 1 |
| Krysan, DJ; Montoya, MC | 1 |
| Abadi, AH; Ahmed, NS; Hassan, AS; Vollmer, G; Wober, J | 1 |
2 review(s) available for triphenylethylene and tamoxifen
| Article | Year |
|---|---|
Speculation on the mechanism of action of triphenylethylene antioestrogens.
Topics: Animals; Binding Sites; Breast Neoplasms; Estradiol; Estrogen Antagonists; Estrogen Replacement Therapy; Humans; Receptors, Estrogen; Stilbenes; Tamoxifen | 1994 |
Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease.
Topics: Animals; Bacteria; Communicable Diseases; Drug Repositioning; Estrogen Receptor Antagonists; Female; Humans; Mice; Parasites; Stilbenes; Tamoxifen; Toremifene; Viruses | 2018 |
20 other study(ies) available for triphenylethylene and tamoxifen
| Article | Year |
|---|---|
The antioxidant action of ketoconazole and related azoles: comparison with tamoxifen and cholesterol.
Topics: Animals; Antioxidants; Ascorbic Acid; Brain; Cattle; Cholesterol; Ergosterol; Estrogen Antagonists; Ferric Compounds; Iron; Ketoconazole; Lipid Peroxidation; Liposomes; Male; Microsomes, Liver; Phospholipids; Rats; Stilbenes; Tamoxifen | 1991 |
Subcellular localization of triphenylethylene antiestrogen binding sites (TABS) in rat liver.
Topics: Animals; Cell Fractionation; Cell Nucleus; Charcoal; Dextrans; Estrogen Antagonists; Female; Liver; Microsomes, Liver; Mitochondria, Liver; Potassium Chloride; Rats; Rats, Inbred Strains; Stilbenes; Tamoxifen | 1986 |
Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Calmodulin; Estradiol; Estrogen Antagonists; Nafoxidine; Stilbenes; Structure-Activity Relationship; Tamoxifen | 1986 |
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Breast Neoplasms; Calmodulin; Cell Division; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 1; Estrogen Antagonists; Female; Humans; Protein Kinase C; Stilbenes; Tamoxifen; Tetradecanoylphorbol Acetate | 1986 |
Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme.
Topics: Adenosine Triphosphate; Animals; Binding Sites; Binding, Competitive; Chromatography, Agarose; Peptide Fragments; Protein Kinase C; Rats; Stilbenes; Tamoxifen | 1988 |
Triphenylethylenes: a new class of protein kinase C inhibitors.
Topics: Animals; Brain; Cells, Cultured; Estrogen Antagonists; Fibroblasts; Mice; Phorbol 12,13-Dibutyrate; Phorbol Esters; Protein Kinase C; Rats; Stilbenes; Structure-Activity Relationship; Tamoxifen | 1986 |
Triphenylethylene antiestrogen binding sites (TABS) specificity.
Topics: Animals; Binding Sites; Cholesterol; Estrogen Antagonists; Female; In Vitro Techniques; Rats; Rats, Inbred Strains; Receptors, Drug; Receptors, Estrogen; Stilbenes; Structure-Activity Relationship; Tamoxifen; Trifluoperazine | 1987 |
Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer.
Topics: Binding Sites; Breast Neoplasms; Humans; In Vitro Techniques; Receptors, Drug; Receptors, Estrogen; Stilbenes; Tamoxifen | 1986 |
Estrogenic effect of tamoxifen and its derivatives on the proliferation of MCF7 human breast tumor cells.
Topics: Breast Neoplasms; Cell Division; Cell Line; Culture Media; Estrogens; Female; Humans; Stilbenes; Tamoxifen | 1985 |
Characterization of a triphenylethylene-antiestrogen-binding site on rat serum low density lipoprotein.
Topics: Animals; Binding Sites; Binding, Competitive; Estrogen Antagonists; Female; Kinetics; Lipoproteins, LDL; Male; Protein Binding; Rats; Rats, Inbred Strains; Stilbenes; Tamoxifen | 1983 |
Species specificity of triphenylethylene derivatives and of compounds with a steroidal backbone for human and rat liver antioestrogen binding site (AEBS).
Topics: Animals; Benzofurans; Binding Sites; Binding, Competitive; Estrogen Antagonists; Humans; Mitochondria, Liver; Rats; Rats, Wistar; Regression Analysis; Species Specificity; Stilbenes; Tamoxifen | 1993 |
Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity.
Topics: Animals; Blotting, Northern; Clomiphene; Dose-Response Relationship, Drug; Endothelial Growth Factors; Estradiol; Estrogen Antagonists; Estrogens; Female; Lymphokines; Nafoxidine; Ovariectomy; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stilbenes; Tamoxifen; Time Factors; Uterus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1997 |
Synthesis and preliminary in vitro cytotoxic activity of novel cisplatin and carboplatin analogues.
Topics: Antineoplastic Agents; Breast Neoplasms; Carboplatin; Cisplatin; Diamines; Female; Humans; In Vitro Techniques; Platinum Compounds; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 1998 |
Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stilbenes; Tamoxifen; Time Factors; Toremifene; Tumor Cells, Cultured | 2000 |
Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.
Topics: Cinnamates; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Genes, Regulator; HeLa Cells; Humans; Protein Binding; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Transcription Factor AP-1; Transcription, Genetic | 2001 |
Okadaic acid-sensitive activation of Maxi Cl(-) channels by triphenylethylene antioestrogens in C1300 mouse neuroblastoma cells.
Topics: Animals; Carcinogens; Chloride Channels; Chlorides; Cyclic AMP; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Ion Channel Gating; Mice; Neuroblastoma; Okadaic Acid; Patch-Clamp Techniques; Phosphoprotein Phosphatases; Phosphorylation; Selective Estrogen Receptor Modulators; Signal Transduction; Staurosporine; Stilbenes; Tamoxifen; Toremifene; Tumor Cells, Cultured | 2001 |
Tamoxifen stimulates calcium entry into human platelets.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Calcium; Calcium Signaling; Diethylstilbestrol; Drug Synergism; Estradiol; Estrenes; Estrogen Antagonists; Ethamoxytriphetol; Female; Fulvestrant; Humans; Male; Middle Aged; Molecular Structure; Phosphodiesterase Inhibitors; Pyrrolidinones; Stilbenes; Structure-Activity Relationship; Tamoxifen; Thrombin; Vasopressins | 2007 |
Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.
Topics: Cytotoxins; Enzyme Activation; Estrogen Antagonists; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Lipid Metabolism; Phosphotransferases (Alcohol Group Acceptor); Sphingolipids; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 2015 |
Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer.
Topics: Breast Neoplasms; Cell Proliferation; Cell Survival; Crystallography, X-Ray; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Receptors, Estrogen; Stilbenes; Tamoxifen | 2018 |
Flexible Etherified and Esterified Triphenylethylene Derivatives and Their Evaluation on ER-positive and Triple-Negative Breast Cancer Cell Lines.
Topics: Breast Neoplasms; Female; Humans; MCF-7 Cells; Stilbenes; Tamoxifen; Triple Negative Breast Neoplasms | 2022 |